Posters
« Back
In vitro selection & validation of synthetic single-domain antibodies & applications
EP28597
Poster Title: In vitro selection & validation of synthetic single-domain antibodies & applications
Submitted on 16 May 2018
Author(s): Stéphanie Blachon1, Sandrine Moutel2, Selma Djander1&2, Vincent Collura1, Alexis Arrial1, Aurélien Olichon4, Franck Perez3, Jean-Christophe Rain1
Affiliations: 1Hybrigenics Services SAS, Paris, France; 2 Translational Research Department, Institut Curie, Paris, France; 3 CNRS UMR144, Institut Curie, Paris, France; 4 INSERM, CRCT, Toulouse, France
This poster was presented at Stem Cells and Antibodies in Drug Discovery Europe 2018
Poster Views: 751
View poster »


Poster Information
Abstract: Antibodies represent central tools in most biological studies to analyze protein localization and function. One of the remaining limitations is the challenge to make them work inside a living cell. For this purpose intrabodies can be selected as powerful tools to answer complex biological questions, like for example conformational intrabody recognizing specifically the GTP-bound form of the small GTPase Rab6.
So far, the access to intrabodies was limited to highly trained lab specialists. We have therefore set up a new platform for intrabody screening and designed for this purpose a fully synthetic humanized naïve Llama VHH library containing 3x10exp9 antibodies, based on a unique scaffold with random complementary determining regions (CDRs). We use a combination of phage display and subsequent yeast two-hybrid (Y2H) screening to identify antibodies against native antigens and eventually intrabodies. The VHH clones are directly accessible and the recombinant antibodies can be produced as fusions to either a human, mouse or rabbit Fc domain.
We successfully selected from this library VHH against a variety of antigens some of which will be exemplified, like intrabodies against GFP, p53 and USP7 (1). The affinity of our VHH is similar to the affinity of antibodies selected after animal immunization.

Summary: Discover our new service for the selection/validation of antibodies. The single-chain Abs can be fused to a tag of your choice (fluorescent markers, enzymes, multi-Fc species) resulting in fully-functional recombinant Abs for in vitro and in vivo applications (ELISA, IF…). References: 1) Moutel S. et al. Elife 2016, 19 : 5Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Functional Assay of Neural Activity with Cell-Based Neural Culture Models and Microelectrode Array Technology for Proconvulsant Risk Assessment in the Neutox Pilot Study
Millard, D.C.; Hayes, H.B.; Nicolini, A.M.; Arrowood, C.A.; Clements, M;

Multiplex miRNA Profiling for Biomarker Discovery and Verification Studies Using the FirePlex® Platform
M. Tackett, B. Heinrich, I. Diwan, G. Tejada, C. Rafferty, E. Atabakhsh, and D. Pregibon

Accelerating high-throughput screening with FirePlex®-HT:An automatable, multiplex immunoassay using FirePlex® Particle Technology
A. Perea, B. Heinrich, W. Austin, C. Rafferty, M. Camilleri, L. To, E. Atabakhsh, and D. Pregibon

PEAKS™ Software for the processing of timsTOF Pro PASEF data: identification and label-free quantitation
Markus Lubeck(1), Heiner Koch(1), Scarlet Beck(1), Paul Savage(2), Oliver Raether(1), Pierre-Olivier Schmit(2) Paul Shan (3) and Gary Kruppa (4)

Plasma proteomic profiling one year postpartum of women with Pre-eclampsia shows dysregulated cardiometabolic profile
Fatma S. Abad, Antigoni Manousopoulou, Diana J. Garay-Baquero, Brian R. Birch, Bas B. van Rijn, Spiros D. Garbis and Bashir A. Lwaleed